Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53.17	55.63	68.74	86.33	94.39	95.82
Short-Term Investments	-	-	-	-	-	2.5
Cash & Short-Term Investments	53.17	55.63	68.74	86.33	94.39	98.32
Cash Growth	-15.37%	-19.07%	-20.37%	-8.54%	-4.00%	-46.84%
Accounts Receivable	23.96	23.59	26.36	34.63	29.84	24.1
Inventory	16.92	23.81	24.43	39.77	36.01	46.21
Other Current Assets	5.27	10.62	43.78	8.83	8.29	8.75
Total Current Assets	99.32	113.65	163.31	169.55	168.53	177.38
Net Property, Plant & Equipment	65.81	64.68	65	78.98	68.56	73.23
Other Intangible Assets	1.66	2.49	2.58	74.6	82.38	91.16
Goodwill	8.06	7.13	7.57	7.34	7.78	8.41
Other Long-Term Assets	12.84	14.79	32.18	18.67	20.29	15.42
Total Assets	187.68	202.74	270.63	349.13	347.54	365.61
Accounts Payable	4.77	5.62	6.19	9.07	7.63	8.98
Accrued Expenses	11.31	13.57	14.07	18.84	17.85	14.79
Other Current Liabilities	-	4.12	10.8	-	4.32	13.09
Total Current Liabilities	16.08	23.31	31.06	27.91	29.8	36.87
Long-Term Leases	23.17	24.01	25.92	28.82	19.24	20.88
Other Long-Term Liabilities	0.76	1.43	1.39	6.83	11.42	35.46
Total Long-Term Liabilities	23.93	25.45	27.31	35.65	30.66	56.34
Total Liabilities	40.01	48.75	58.37	63.57	60.45	93.21
Common Stock	0.14	0.14	0.15	0.15	0.14	0.14
Additional Paid-in Capital	89.46	88.96	90.01	81.14	67.08	55.36
Accumulated Other Comprehensive Income	-4.76	-6.78	-5.94	-6.44	-5.72	-4.54
Retained Earnings	62.82	71.67	128.05	210.72	225.58	221.44
Shareholders' Equity	147.67	153.99	212.27	285.56	287.09	272.4
Total Liabilities & Equity	187.68	202.74	270.63	349.13	347.54	365.61
Total Debt	23.17	24.01	25.92	28.82	19.24	20.88
Net Cash (Debt)	29.99	31.62	42.83	57.51	75.15	77.44
Net Cash Growth	-5.13%	-26.18%	-25.54%	-23.47%	-2.96%	-52.66%
Net Cash Per Share	2.06	2.15	2.92	3.89	5.13	5.45
Book Value	147.67	153.99	212.27	285.56	287.09	272.4
Book Value Per Share	10.16	10.46	14.48	19.31	19.62	19.15
Tangible Book Value	137.96	144.37	202.12	203.63	196.92	172.83
Tangible Book Value Per Share	9.49	9.81	13.79	13.77	13.46	12.15

Updated Jul 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q